Valuation: Consort Medical plc

Market Cap 502M 448M 414M 375M 702M 47.65B 714M 4.98B 1.97B 24.96B 1.88B 1.84B 78.7B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 535M 494M 448M 838M 56.89B 852M 5.95B 2.36B 29.81B 2.25B 2.2B 93.98B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 52 31/03/2024
Director/Board Member 46 31/01/2023
Director/Board Member 53 31/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
06/02/20 Sell 211,474 0.4284%
06/02/20 Exercice 211,474 0.4284%
06/02/20 Sell 467 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
+1.16%-1.13%-18.25%+10.83% 179B
+0.02%+4.24%-19.55%+18.56% 118B
-1.22%+0.70%+1.86%+33.63% 117B
+2.29%+17.36%-42.18%+7.49% 93.26B
-2.21%-2.91%-0.51%+75.02% 63.16B
-0.50%+1.47%+6.61%+80.12% 55.68B
-0.75%+3.73%+7.04%-22.17% 54.18B
-1.13%+0.00%-12.56%+35.79% 44.15B
+0.17%+5.85%-5.20%-10.34% 33.95B
Average -0.22%+3.01%-9.19%+25.44% 75.91B
Weighted average by Cap. +0.03%+3.05%-12.27%+23.71%

Financials

2018 2019
Net sales 311M 278M 257M 233M 435M 29.53B 442M 3.09B 1.22B 15.47B 1.17B 1.14B 48.78B 305M 272M 252M 228M 427M 28.96B 434M 3.03B 1.2B 15.17B 1.15B 1.12B 47.84B
Net income 16.1M 14.38M 13.28M 12.04M 22.52M 1.53B 22.89M 160M 63.28M 801M 60.42M 59.14M 2.52B 10.5M 9.38M 8.66M 7.85M 14.69M 997M 14.93M 104M 41.27M 522M 39.41M 38.57M 1.65B
Net Debt 95.5M 85.28M 78.78M 71.4M 134M 9.07B 136M 948M 375M 4.75B 358M 351M 14.97B 97.4M 86.98M 80.35M 72.82M 136M 9.25B 138M 967M 383M 4.84B 366M 358M 15.27B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock